Novel GLP-1 analogs having improved biological potency as well as extended pharmacological activity are described herein. More specifically, the present invention relates to GLP-1 analogs (28 or 29 aa long) comprising amino acid substitutions at one or more of the following positions: 8, 20, 27, 30 and 33.
                            本发明描述的新型 GLP-1 类似物具有更好的
生物效力和更强的药理活性。更具体地说,本发明涉及的 GLP-1 类似物(28 或 29 aa 长)包含以下一个或多个位置的
氨基酸置换:8、20、27、30 和 33。